Thin basement membrane disease cost-effectiveness of therapy
|
Thin basement membrane disease Microchapters |
|
Differentiating Thin basement membrane disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Thin basement membrane disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Thin basement membrane disease cost-effectiveness of therapy |
|
FDA on Thin basement membrane disease cost-effectiveness of therapy |
|
CDC on Thin basement membrane disease cost-effectiveness of therapy |
|
Thin basement membrane disease cost-effectiveness of therapy in the news |
|
Blogs on Thin basement membrane disease cost-effectiveness of therapy |
|
Directions to Hospitals Treating Thin basement membrane disease |
|
Risk calculators and risk factors for Thin basement membrane disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]
Overview
The cost of the supportive therapy for symptoms are not very expensive except long term dialysis and renal transplantation.
Cost-effectiveness
The cost-effectiveness of the supportive therapy for symptoms are not very costly. But patient with Renal impairment or renal failure should be counselled on cost of a long tern dialysis or renal transplantation. Moreover, the frequency of screening procedures may cause burden to a patient or the family's physical and mental health. The importance of early diagnosis and treatment should be explained in meaningful way.